These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 19781424

  • 1. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study.
    Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y.
    Am Heart J; 2009 Oct; 158(4):629-36. PubMed ID: 19781424
    [Abstract] [Full Text] [Related]

  • 2. Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study.
    Watanabe H, Obata H, Watanabe T, Sasaki S, Nagai K, Aizawa Y.
    Diabetes Metab Res Rev; 2010 Jan; 26(1):26-32. PubMed ID: 20014332
    [Abstract] [Full Text] [Related]

  • 3. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM, Wachtell K, Kjeldsen SE, Julius S, Lindholm LH, Dahlöf B, Hille DA, Nieminen MS, Edelman JM, Devereux RB.
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [Abstract] [Full Text] [Related]

  • 4. Relation of atrial fibrillation to glomerular filtration rate.
    Iguchi Y, Kimura K, Kobayashi K, Aoki J, Terasawa Y, Sakai K, Uemura J, Shibazaki K.
    Am J Cardiol; 2008 Oct 15; 102(8):1056-9. PubMed ID: 18929708
    [Abstract] [Full Text] [Related]

  • 5. ST-segment abnormalities and premature complexes are predictors of new-onset atrial fibrillation: the Niigata preventive medicine study.
    Watanabe H, Tanabe N, Makiyama Y, Chopra SS, Okura Y, Suzuki H, Matsui K, Watanabe T, Kurashina Y, Aizawa Y.
    Am Heart J; 2006 Oct 15; 152(4):731-5. PubMed ID: 16996849
    [Abstract] [Full Text] [Related]

  • 6. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.
    Horio T, Iwashima Y, Kamide K, Tokudome T, Yoshihara F, Nakamura S, Kawano Y.
    J Hypertens; 2010 Aug 15; 28(8):1738-44. PubMed ID: 20485194
    [Abstract] [Full Text] [Related]

  • 7. [Chronic renal disease and atrial fibrillation in patients with chronic heart failure].
    Shutov AM, Serov VA, Kurzina EV, Gerdt AM, Serova DV.
    Ter Arkh; 2009 Aug 15; 81(12):23-6. PubMed ID: 20481043
    [Abstract] [Full Text] [Related]

  • 8. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study.
    Ninomiya T, Kiyohara Y, Tokuda Y, Doi Y, Arima H, Harada A, Ohashi Y, Ueshima H, Japan Arteriosclerosis Longitudinal Study Group.
    Circulation; 2008 Dec 16; 118(25):2694-701. PubMed ID: 19106392
    [Abstract] [Full Text] [Related]

  • 9. Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan.
    Iseki K, Iseki C, Ikemiya Y, Kinjo K, Takishita S.
    Hypertens Res; 2007 Feb 16; 30(2):167-74. PubMed ID: 17460387
    [Abstract] [Full Text] [Related]

  • 10. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Haywood LJ, Ford CE, Crow RS, Davis BR, Massie BM, Einhorn PT, Williard A, ALLHAT Collaborative Research Group.
    J Am Coll Cardiol; 2009 Nov 24; 54(22):2023-31. PubMed ID: 19926008
    [Abstract] [Full Text] [Related]

  • 11. [Incidence, prevalence, and mortality estimates for chronic atrial fibrillation in Turkish adults].
    Uyarel H, Onat A, Yüksel H, Can G, Ordu S, Dursunoğlu D.
    Turk Kardiyol Dern Ars; 2008 Jun 24; 36(4):214-22. PubMed ID: 18765964
    [Abstract] [Full Text] [Related]

  • 12. Annual incidence of atrial fibrillation and related factors in adults.
    Iguchi Y, Kimura K, Shibazaki K, Aoki J, Kobayashi K, Sakai K, Sakamoto Y.
    Am J Cardiol; 2010 Oct 15; 106(8):1129-33. PubMed ID: 20920652
    [Abstract] [Full Text] [Related]

  • 13. Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
    Lemola K, Khan R, Nattel S, Talajic M, Roy D, Guerra PG, Lemola S, Dubuc M, Thibault B, Macle L, Khairy P.
    Pacing Clin Electrophysiol; 2009 Jan 15; 32(1):99-105. PubMed ID: 19140919
    [Abstract] [Full Text] [Related]

  • 14. Prognosis of transient new-onset atrial fibrillation during vascular surgery.
    Winkel TA, Schouten O, Hoeks SE, Verhagen HJ, Bax JJ, Poldermans D.
    Eur J Vasc Endovasc Surg; 2009 Dec 15; 38(6):683-8. PubMed ID: 19683947
    [Abstract] [Full Text] [Related]

  • 15. Alcohol consumption and risk and prognosis of atrial fibrillation among older adults: the Cardiovascular Health Study.
    Mukamal KJ, Psaty BM, Rautaharju PM, Furberg CD, Kuller LH, Mittleman MA, Gottdiener JS, Siscovick DS.
    Am Heart J; 2007 Feb 15; 153(2):260-6. PubMed ID: 17239687
    [Abstract] [Full Text] [Related]

  • 16. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study.
    Djoussé L, Levy D, Benjamin EJ, Blease SJ, Russ A, Larson MG, Massaro JM, D'Agostino RB, Wolf PA, Ellison RC.
    Am J Cardiol; 2004 Mar 15; 93(6):710-3. PubMed ID: 15019874
    [Abstract] [Full Text] [Related]

  • 17. Asymptomatic isolated microscopic haematuria: long-term follow-up.
    Chow KM, Kwan BC, Li PK, Szeto CC.
    QJM; 2004 Nov 15; 97(11):739-45. PubMed ID: 15496530
    [Abstract] [Full Text] [Related]

  • 18. Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis.
    Ruigómez A, Johansson S, Wallander MA, Edvardsson N, García Rodríguez LA.
    Int J Cardiol; 2009 Aug 14; 136(2):186-92. PubMed ID: 18625526
    [Abstract] [Full Text] [Related]

  • 19. Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure.
    Adabag AS, Nelson DB, Bloomfield HE.
    Am Heart J; 2007 Dec 14; 154(6):1140-5. PubMed ID: 18035087
    [Abstract] [Full Text] [Related]

  • 20. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.